| Code | Description | Claims | Beneficiaries | Total Paid |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
15,334 |
14,892 |
$2.11M |
| G0378 |
Hospital observation service, per hour |
2,353 |
888 |
$446K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,722 |
4,598 |
$430K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,467 |
2,386 |
$410K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,175 |
1,149 |
$160K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,717 |
5,441 |
$111K |
| T1015 |
Clinic visit/encounter, all-inclusive |
3,456 |
3,169 |
$97K |
| 80053 |
Comprehensive metabolic panel |
9,204 |
8,493 |
$72K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,469 |
14,843 |
$67K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
250 |
245 |
$51K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
315 |
313 |
$47K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,298 |
2,903 |
$45K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
660 |
651 |
$43K |
| 70450 |
Computed tomography, head or brain; without contrast material |
946 |
912 |
$42K |
| 64415 |
|
125 |
125 |
$37K |
| 80050 |
General health panel |
851 |
844 |
$37K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
573 |
556 |
$35K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
279 |
276 |
$34K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
515 |
503 |
$29K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
196 |
193 |
$28K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
137 |
134 |
$28K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
118 |
116 |
$27K |
| 72141 |
|
117 |
116 |
$26K |
| 93975 |
|
280 |
271 |
$26K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,628 |
3,431 |
$26K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
690 |
684 |
$21K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,978 |
3,301 |
$21K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
357 |
352 |
$20K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
108 |
108 |
$20K |
| 84443 |
Thyroid stimulating hormone (TSH) |
967 |
946 |
$19K |
| J3490 |
Unclassified drugs |
4,328 |
3,014 |
$18K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
310 |
302 |
$18K |
| 71046 |
Radiologic examination, chest; 2 views |
1,268 |
1,224 |
$16K |
| 80061 |
Lipid panel |
1,267 |
1,256 |
$16K |
| 93971 |
|
298 |
287 |
$16K |
| 71250 |
|
291 |
282 |
$15K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
527 |
442 |
$14K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
99 |
99 |
$14K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
112 |
110 |
$13K |
| 76536 |
|
271 |
265 |
$12K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
307 |
292 |
$12K |
| 84484 |
|
1,817 |
1,648 |
$11K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
357 |
353 |
$11K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
258 |
251 |
$11K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
27 |
26 |
$11K |
| 71045 |
Radiologic examination, chest; single view |
2,169 |
2,064 |
$11K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
266 |
259 |
$11K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
215 |
210 |
$11K |
| 83605 |
|
2,026 |
1,916 |
$11K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
44 |
44 |
$10K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
105 |
81 |
$10K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
826 |
625 |
$9K |
| 85730 |
|
1,948 |
1,867 |
$9K |
| 83735 |
|
2,062 |
1,649 |
$9K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
5,945 |
5,521 |
$8K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
216 |
167 |
$8K |
| 83690 |
|
2,313 |
2,169 |
$8K |
| 76770 |
|
184 |
179 |
$7K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
845 |
824 |
$7K |
| 85610 |
|
2,920 |
2,544 |
$7K |
| 83880 |
|
318 |
306 |
$7K |
| 84439 |
|
915 |
900 |
$6K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
226 |
223 |
$6K |
| 82607 |
|
551 |
545 |
$6K |
| 87040 |
|
499 |
312 |
$6K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
967 |
954 |
$6K |
| 72100 |
|
355 |
347 |
$6K |
| 80076 |
|
859 |
816 |
$5K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
12 |
12 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
188 |
180 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
831 |
584 |
$5K |
| 93017 |
|
169 |
165 |
$5K |
| 82728 |
|
462 |
448 |
$5K |
| 84702 |
|
534 |
490 |
$5K |
| 86803 |
|
276 |
276 |
$5K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
140 |
136 |
$5K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
798 |
758 |
$4K |
| 81025 |
|
1,532 |
1,382 |
$4K |
| 62323 |
|
69 |
67 |
$4K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
1,001 |
977 |
$4K |
| 73610 |
|
267 |
262 |
$4K |
| 85379 |
|
454 |
445 |
$4K |
| Q3014 |
Telehealth originating site facility fee |
233 |
221 |
$4K |
| 86618 |
|
198 |
194 |
$4K |
| 85027 |
|
967 |
785 |
$3K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
8,915 |
5,793 |
$3K |
| 83540 |
|
439 |
433 |
$3K |
| 73564 |
|
194 |
192 |
$3K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
135 |
131 |
$3K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
6,777 |
3,315 |
$3K |
| 73630 |
|
365 |
359 |
$3K |
| 72158 |
|
12 |
12 |
$3K |
| 81001 |
|
1,268 |
1,211 |
$3K |
| 73502 |
|
174 |
167 |
$3K |
| 73030 |
|
235 |
229 |
$2K |
| 87077 |
|
417 |
407 |
$2K |
| 85652 |
|
969 |
920 |
$2K |
| 81003 |
|
968 |
928 |
$2K |
| 82565 |
|
495 |
472 |
$2K |
| 90715 |
|
217 |
213 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
209 |
96 |
$2K |
| 86140 |
|
889 |
835 |
$2K |
| 84100 |
|
476 |
381 |
$2K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
160 |
98 |
$2K |
| 86038 |
|
157 |
153 |
$2K |
| 74018 |
|
233 |
215 |
$2K |
| 84153 |
|
81 |
81 |
$2K |
| 76830 |
Ultrasound, transvaginal |
59 |
58 |
$2K |
| 73130 |
|
214 |
208 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
5,452 |
4,890 |
$2K |
| 93226 |
|
63 |
59 |
$2K |
| 87186 |
|
320 |
310 |
$2K |
| 72110 |
|
93 |
93 |
$2K |
| 83550 |
|
402 |
396 |
$2K |
| 86850 |
|
415 |
396 |
$2K |
| 82043 |
|
219 |
219 |
$2K |
| 82550 |
|
281 |
270 |
$2K |
| 82977 |
|
190 |
166 |
$1K |
| 82746 |
|
128 |
124 |
$1K |
| 73110 |
|
137 |
134 |
$1K |
| 93970 |
|
25 |
25 |
$1K |
| 72040 |
|
101 |
100 |
$1K |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
135 |
132 |
$1K |
| 82962 |
|
1,132 |
691 |
$1K |
| 84403 |
|
46 |
45 |
$1K |
| 84703 |
|
247 |
241 |
$1K |
| 82784 |
|
50 |
50 |
$956.93 |
| 87070 |
|
285 |
269 |
$939.89 |
| 83615 |
|
142 |
101 |
$894.50 |
| 72050 |
|
37 |
37 |
$876.35 |
| 86901 |
|
427 |
408 |
$834.42 |
| 86900 |
|
428 |
409 |
$828.25 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
305 |
273 |
$817.60 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
44 |
42 |
$760.66 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,401 |
5,323 |
$753.23 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
44 |
42 |
$744.74 |
| C9399 |
Unclassified drugs or biologicals |
182 |
170 |
$740.09 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,654 |
1,182 |
$737.84 |
| 93225 |
|
46 |
44 |
$689.63 |
| 70486 |
|
12 |
12 |
$682.00 |
| 82805 |
|
26 |
24 |
$678.16 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
3,287 |
2,641 |
$645.44 |
| 86617 |
|
24 |
24 |
$638.36 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,738 |
6,939 |
$633.94 |
| 87340 |
|
47 |
47 |
$630.96 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
495 |
489 |
$608.96 |
| 87205 |
|
288 |
271 |
$603.75 |
| 82330 |
|
74 |
66 |
$579.22 |
| 84550 |
|
102 |
91 |
$552.40 |
| 82150 |
|
145 |
142 |
$517.76 |
| 87081 |
|
140 |
137 |
$509.30 |
| 85014 |
|
234 |
206 |
$486.28 |
| 88342 |
|
28 |
28 |
$481.51 |
| 83970 |
|
13 |
12 |
$475.06 |
| 84520 |
|
108 |
97 |
$467.35 |
| 85018 |
|
217 |
190 |
$463.11 |
| 88313 |
|
25 |
25 |
$453.20 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,102 |
2,781 |
$453.10 |
| 84450 |
|
70 |
63 |
$448.09 |
| 76942 |
|
224 |
223 |
$435.72 |
| 86706 |
|
33 |
33 |
$418.91 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
15 |
$393.94 |
| 84460 |
|
65 |
62 |
$388.94 |
| 72072 |
|
24 |
24 |
$379.65 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
852 |
716 |
$377.70 |
| 87430 |
|
78 |
77 |
$373.05 |
| J1644 |
Injection, heparin sodium, per 1000 units |
1,436 |
571 |
$354.85 |
| 80329 |
|
24 |
24 |
$337.69 |
| 93296 |
|
25 |
25 |
$328.23 |
| J3535 |
Drug administered through a metered dose inhaler |
57 |
54 |
$302.75 |
| 88304 |
|
164 |
161 |
$299.26 |
| 73590 |
|
29 |
28 |
$294.12 |
| 96415 |
|
13 |
12 |
$293.90 |
| J8501 |
Aprepitant, oral, 5 mg |
13 |
13 |
$266.24 |
| 73080 |
|
29 |
28 |
$263.85 |
| 86431 |
|
31 |
30 |
$223.79 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
56 |
39 |
$211.25 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
35 |
25 |
$201.66 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
961 |
761 |
$173.77 |
| 82570 |
|
28 |
25 |
$168.55 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
449 |
368 |
$167.43 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,576 |
1,360 |
$152.50 |
| 97162 |
|
12 |
12 |
$137.94 |
| 86592 |
|
30 |
30 |
$124.44 |
| 88307 |
|
82 |
82 |
$116.50 |
| 73090 |
|
14 |
13 |
$112.71 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
149 |
138 |
$107.38 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,854 |
2,431 |
$106.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
968 |
593 |
$96.30 |
| 86376 |
|
12 |
12 |
$88.82 |
| 96376 |
|
97 |
53 |
$87.13 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
180 |
129 |
$82.67 |
| 73562 |
|
15 |
13 |
$80.10 |
| 73140 |
|
14 |
14 |
$76.40 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
733 |
632 |
$74.78 |
| 36415 |
Collection of venous blood by venipuncture |
721 |
565 |
$69.86 |
| 97161 |
|
17 |
16 |
$67.97 |
| 97165 |
|
15 |
14 |
$67.90 |
| 86308 |
|
14 |
13 |
$64.24 |
| 84156 |
|
15 |
12 |
$64.08 |
| J2704 |
Injection, propofol, 10 mg |
2,898 |
2,684 |
$52.91 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
28 |
26 |
$52.46 |
| 82947 |
|
27 |
27 |
$48.00 |
| J2060 |
Injection, lorazepam, 2 mg |
464 |
362 |
$46.87 |
| J3480 |
Injection, potassium chloride, per 2 meq |
78 |
37 |
$30.50 |
| S0028 |
Injection, famotidine, 20 mg |
172 |
140 |
$10.82 |
| 94761 |
|
15 |
12 |
$9.87 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
398 |
333 |
$9.09 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
366 |
236 |
$6.58 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
41 |
24 |
$3.56 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
32 |
25 |
$0.84 |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
165 |
144 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
128 |
100 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
32 |
30 |
$0.00 |
| 76937 |
|
12 |
12 |
$0.00 |
| S0077 |
Injection, clindamycin phosphate, 300 mg |
16 |
13 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
959 |
832 |
$0.00 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
289 |
267 |
$0.00 |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
336 |
329 |
$0.00 |
| J7999 |
Compounded drug, not otherwise classified |
1,000 |
816 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
41 |
39 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
12 |
12 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
13 |
12 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
12 |
12 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
12 |
12 |
$0.00 |